ABSTRACT

Prescription Drug Monitoring Programs: Views on Usefulness and Challenges of Programs, Report to Congressional Committees   [open pdf - 1MB]

From the Highlights: "Prescription medications-- particularly when misused or overprescribed--can contribute to dangerous drug interactions, substance use disorder, overdoses, and deaths. The federal government has identified PDMPs [prescription drug monitoring programs] as key tools to help ensure the safe and appropriate prescribing of opioids and other controlled substances. The Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act includes a provision for GAO [Government Accountability Office] to study the operation of PDMPs. In this report, GAO describes (1) physicians' views on the usefulness of PDMPs when making patient care decisions; and (2) challenges to using PDMPs when making patient care decisions, as well as state and federal efforts to address these challenges."

Report Number:
GAO-21-22
Publisher:
Date:
2020-10
Copyright:
Public Domain
Retrieved From:
Government Accountability Office: https://www.gao.gov/
Format:
pdf
Media Type:
application/pdf
URL:
Help with citations